NBIO Share Price Performance
US$0.0029
-0.06 (-95.54%)
Price US$0.0029
Share Pricen/a
Nascent Biotech, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NBIO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Nascent Biotech, Inc. Key Details
About NBIO
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.
